
Trump's trade war has cost firms $34 billion — Reuters
Multi-national companies have suffered $34 billion in losses due to tariffs imposed by US President Donald Trump, according to a Reuters analysis. The measures have disrupted businesses and heightened tensions with Washington's key allies, notably the EU.
The report, based on disclosures from 56 firms across the US, Europe, and Japan, attributes the losses to higher input costs, revenue losses, and supply chain uncertainty. Economists have warned the real cost could be far higher, owing to ripple effects including weaker investment, reduced consumer spending, and rising inflation risks.
Trump has rolled out sweeping duties since returning to office in January, in the name of protecting US manufacturing which culminated in his 'Liberation Day' tariffs on April 2 that included a universal 10% levy on all imports and a threatened 50% rate on EU goods.
'The Administration has consistently maintained that the United States, as the world's largest economy, has the leverage to make our trading partners ultimately bear the cost of tariffs,' said White House spokesperson Kush Desai. However, data suggests American businesses are footing the bill, while relations with Washington's allies have grown increasingly strained.
The EU prepared countermeasures targeting €100 billion worth of American goods, including cars, medical devices, and plastics. After a call between Trump and European Commission President Ursula von der Leyen, the 50% duties were delayed until July 9 to allow room for negotiation.
Apple, Ford, Kimberly-Clark, Walmart, and others have warned of rising costs and lowered their own forecasts, blaming Trump's 'erratic' trade approach, Reuters reported. One of the few to endorse the measures is General Motors, which has backed the auto tariffs, arguing they allow US automakers to compete more fairly.
Trump has defended his tariff strategy as a way of reshoring jobs and reducing the trade deficit. 'We're going to raise hundreds of billions in tariffs; we're going to become so rich we're not going to know where to spend that money,' he said in March.
According to the Tax Foundation, tariffs imposed and scheduled for 2025 are projected to raise $152.7 billion in federal revenue, equivalent to 0.49% of GDP, the largest tax increase since 1993.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Russia Today
3 hours ago
- Russia Today
Popular weight loss drug raises risk of ‘silent' cancer
Ozempic and similar weight loss medications may increase the risk of kidney cancer, according to a major study. However, the drugs reportedly lower the risk of more than a dozen other cancers, suggesting their overall benefit may still outweigh the hazards. A recent study presented at the American Society of Clinical Oncology's annual conference in May found that people using popular weight-loss drugs such as Ozempic may have a higher risk of developing kidney cancer, the Daily Mail wrote on Tuesday. Researchers looked at the medical records from more than 86,000 patients in Florida over a ten-year period. They found 83 cases of kidney cancer among people taking weight loss drugs, compared to 58 cases in a similar group who were not taking them. The study showed a 33% higher chance of getting kidney cancer for users of these medications. The drugs are part of a group called GLP-1 drugs, which also includes Wegovy and others. Kidney cancer is known as a 'silent' disease because it often causes no symptoms early on. By the time signs such as blood in the urine, back pain, or a lump appear, it may have already spread, making survival less likely. Dr. Hao Dai from Indiana University, who led the study, told the Daily Mail on Tuesday that the results do not prove the drugs cause kidney cancer, but he called the findings 'concerning' and said more monitoring is needed. Although the risk of kidney cancer was seen to rise, the study also found that the same drugs may lower the chances of getting more than a dozen other cancers linked to obesity, including cancers of the uterus and ovaries. These results support earlier research. A 2023 study of 1.6 million people with diabetes found a 54% higher risk of kidney cancer among those using GLP-1 drugs compared to people using another diabetes medicine called metformin. Doctors believe the increased risk may be linked to side effects like vomiting and dehydration, which can hurt the kidneys. There is also a theory that the way these drugs work in the kidneys may affect how cells grow. Ozempic has also been approved by the US Food and Drug Administration to help protect kidney function in people with Type 2 diabetes and chronic kidney disease. In those patients, the drug lowered the risk of serious kidney problems by 24%, according to research. Medical experts say more research is needed to better understand how these drugs affect long-term kidney health and cancer risk.


Russia Today
3 hours ago
- Russia Today
Indian and Pakistani ‘dueling' delegations land in Washington
Delegations of both Indian and Pakistani diplomats and politicians have arrived in Washington to meet with US officials and present their side of the recent conflict between the two countries. India's delegation led by Shashi Tharoor, an MP for the opposition Indian National Congress party, landed in Washington on Wednesday to present its case about the terrorism allegedly emanating from Pakistan. 'Tomorrow almost they will be in Washington, while we are in Washington on the same date. So there's going to be perhaps an increase in interest because there are two dueling delegations in the same city,' Tharoor said in an interview with the news agency ANI. New Delhi has sent seven teams to over 30 countries to counter what it perceives as poor press coverage about the confrontation with Islamabad. External Affairs ministry spokesperson Randhir Jaiswal said India wants the world to 'hold Pakistan accountable' for what he claimed was 40 years of cross-border terrorism against India. An MP from the ruling Bharatiya Janata Party (BJP) party told the Press Trust of India that the delegations sent across the world will convey India's message of 'zero tolerance against terrorism' and the 'propaganda they (Pakistan) have been doing since 1947.'The Pakistani delegation, which is led by former Foreign Minister Bilawal Bhutto Zardari, was tasked by Pakistani Prime Minister Shehbaz Sharif to 'expose Indian propaganda,' state-run Pakistan Radio reported in May. It traveled to Washington on Wednesday after concluding a two-day visit to the UN headquarters in New York, where it accused India of 'unilateral aggression' and dismissed India's claims about Islamabad's links to the terrorists behind the Kashmir attack. The delegation also proposed that the Pakistani and Indian intelligence agencies could work together to 'decrease' terrorism in South Asia. #WATCH: The world is less safe after the Pakistan-India standoff, even with a ceasefire, as the threshold for full-scale conflict between two nuclear states has risen, says ex-FM Bilawal Bhutto-Zardari at OIC envoy meeting in New New Delhi, however, maintained it will only engage in talks with Islamabad after it takes concrete action against terrorism. 'If Pakistan is as innocent as they claim to be, why do they give a safe haven to wanted terrorists?... Why are they able to live peacefully, to conduct training radicalize further people, to equip arms and get people to practice their arms and Kalashnikovs...,' Tharoor told the PTI agency before heading to Washington. The escalation between the two neighbors began on May 7, when India launched Operation Sindoor against what it called terrorists in Pakistan. This was in response to the terrorist attack in India's Jammu and Kashmir Union Territory in late April that killed 26 tourists. Islamabad denied any involvement in that attack. After a brief but fierce military standoff, a ceasefire was announced on May 10. US President Donald Trump took credit for playing a role in the ceasefire, a claim that New Delhi rejected.


Russia Today
4 hours ago
- Russia Today
Zuma criticizes Trump over genocide claims
Former president Jacob Zuma has affirmed that there is no genocide in South Africa, describing US President Donald Trump as a loudmouth who doesn't know what he is talking about. 'There is no genocide in South Africa, nothing, absolutely nothing. I take it that when people talk about genocide, it is when many people die. There is nothing of that nature in South Africa,' said Zuma during a media briefing in Durban on Tuesday. '[Trump] just talks when he wants to talk, anything. I thought he would know better what genocide is. Now, for him to say so, it's just a joke really,' he added. Zuma told journalists in a media briefing in Durban on Tuesday that Trump was the least of his concerns when he was asked about his views on the US president. 'Why should I worry myself about Trump? We have serious problems here to fix this country. No, I'm not going to talk about that,' Zuma said. President Cyril Ramaphosa recently led a South African delegation to Washington in a bid to reset bilateral relations between the two nations. This comes after organisations claimed that there was a genocide against the white Afrikaners. The government clarified to the US that there was no evidence of genocide in the country. Meanwhile, the MK Party has removed Floyd Shivambu as the secretary-general, confirming that he will be deployed in published by IOL